The reverse Warburg effect and18F-FDG uptake in non-small cell lung cancer A549 in mice a pilot study

Journal of Nuclear Medicine

Volumn 56, Issue 4, 2015, Pages 607-612

  Zhang, Guojian ^a,b   Li, Jianbo ^a,b   Wang, Xuemei ^a   Ma, Yuanyuan ^c   Yin, Xindao ^b,d   Wang, Feng ^d   Zheng, Huaiyu ^b   Duan, Xiaoxian ^b   Postel, Gregory C ^b   Li, Xiao Feng ^b  

^a Inner Mongolia Medical University affiliated Hospital   (China)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

18f fluorodeoxyglucose; Non small cell lung cancer; Pasteur effect; PET; Reverse Warburg effect

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; PIMONIDAZOLE; GLUCOSE BLOOD LEVEL; NITROIMIDAZOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ANAEROBIC GLYCOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DIET RESTRICTION; DRUG TUMOR LEVEL; EX VIVO STUDY; FEEDING; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PASTEUR EFFECT; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVERSE WARBURG EFFECT; TUMOR MICROENVIRONMENT; WARBURG EFFECT; WEIGHT REDUCTION; ANALYSIS; ANIMAL; ANOXIA; BODY WEIGHT; CANCER TRANSPLANTATION; CHEMISTRY; DIAGNOSTIC USE; DIET; LUNG TUMOR; METABOLISM; NUDE MOUSE; SCINTISCANNING; TUMOR CELL LINE;

ANIMALS; ANOXIA; BLOOD GLUCOSE; BODY WEIGHT; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DIET; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NITROIMIDAZOLES; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TUMOR MICROENVIRONMENT;

EID: 84928242135     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.148254     Document Type: Article

References (26)

1. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
2. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029-1033.
3. 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer. J Nucl Med. 2012;53:1262-1268.
4. 18F-fluorodeoxyglucose in oncology application. Transl Oncol. 2014;7:240-247.
5. Pugachev A, Ruan S, Carlin S, et al. Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys. 2005;62:545-553.
6. Busk M, Horsman MR, Kristjansen PE, van der Kogel AJ, Bussink J, Overgaard J. Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. Int J Cancer. 2008;122:2726-2734.
7. 18F-FDG uptake in microscopic peritoneal tumors requires physiological hypoxia. J Nucl Med. 2010;51:632-638.
8. Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995;36:1625-1632.
9. Burgman P, O'Donoghue JA, Humm JL, Ling CC. Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med. 2001;42:170-175.
10. 18F]FDG in cultured prostate cancer cells. Nucl Med Biol. 2006;33:977-984.
11. Busk M, Horsman MR, Jakobsen S, Bussink J, van der Kogel A, Overgaard J. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging. 2008;35:2294-2303.
12. Pavlides S, Whitaker-Menezes D, Castello-Cros R, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009;8:3984-4001.
13. Pavlides S, Tsirigos A, Vera I, et al. Transcriptional evidence for the "reverse Warburg effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "neuron-glia metabolic coupling." Aging (Albany NY). 2010;2:185-199.
14. Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle. 2010;9:1960-1971.
15. Pavlides S, Tsirigos A, Vera I, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle. 2010;9:2201-2219.
16. Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle. 2010;9:2423-2433.
17. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer: a PET study. J Nucl Med. 1993;34:1-6.
18. 18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomas. Tumori. 1997;83:748-752.
19. 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis. J Nucl Med. 2010;51:1015-1020.
20. 18F-FDG uptake in longitudinal mouse PET studies. EJNMMI Res. 2013;3:51.
21. 18F-FDG microPET studies in mouse tumor xenografts. J Nucl Med. 2007;48:602-607.
22. 18F-fluorothymidine PET achieves more complete identification of viable cancer cells in lung cancer of the mouse and the patient than individual radiopharmaceutical: A proof-of-concept study. Transl Oncol. 2013;6:775-783.
23. 131I-IAZGP) digital autoradiography. Eur J Nucl Med Mol Imaging. 2010;37:339-348.
24. Li XF, Carlin S, Urano M, Russell J, Ling CC, O'Donoghue JA. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res. 2007;67:7646-7653.
25. Ljungkvist AS, Bussink J, Kaanders JH, et al. Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys. 2005;62:1157-1168.
26. 18F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70:235-242.